Cooperative Research and Development Agreements (CRADAs) provide nih researchers with an exciting opportunity to pursue common research goals with their industry and science counterparts. Government scientists can use their own research resources and serve the NIH`s greatest mission to facilitate the development and commercialization of medicines and health products. Companies can also leverage their own research and development efforts while collaborating on state-of-the-art RESEARCH in NIH technology. CRADAs, which explicitly seek to lead RESEARCH on NIH, are not appropriate. In addition, when considering a proposed CRADA, it is important to ensure that targeted research has an implicit net effect. For example, the more laboratory resources come from a CRADA, the less likely the laboratory will be to pursue other research opportunities outside of CRADA; The broader the scope of a CRADA research plan, the less equitable access to one laboratory will be possible and interaction with others. Achieving this balance will be taken into account in the decision-making process. It is therefore appropriate to consider that the appointments of research staff will be reviewed and approved by the Scientific Director of the Institute and Centre (SD) or by his representative (unable to exercise a new power of delegation). The SD must approve a document fully outlining research cooperation with each party`s contributions and the applicable research cooperation agreement (see Annexes 1-3 of the NH Policy Manual 2300-308-4. a.
the fraction of resources allocated to a laboratory allocated to CRADA research; On-site research staff (RCs) include scientists, engineers, physicians and other scientific or medical providers who work in research cooperation with NIH Intramural Research Program (IRP) staff and who are authorized by the NIH to conduct scientific studies and studies with IRP staff using nih. Other collaborative research projects with NIH by interacting with IRP investigators and using equipment and other resources in NIH-IRP facilities that are otherwise not accessible to them or are not readily available. There are two types of RCs: (1) those that do not offer direct services for NIH; and (2) those who, as agents or retailers under the Intergovernmental Personnel Act (IAP), provide a number of services to the NIH and act in part under the control and control of the NIH. The specific authorized activities of a RC vary depending on the mechanism used to bring the person to the NIH and the specific needs of the program. RC agreements must be recorded in writing and all RCs must sign a « Research Collaborator Agreement » (see annexes 1-3 of the NH Policy Manual 2300-308-4). Nih researchers are generally free to choose the purpose of their research, in accordance with the mission of their institute and the research programs of their laboratories. No CRADA can infringe this freedom. A CRADA is not designed as a general funding mechanism to support targeted research in a NIH laboratory. Most of a laboratory`s resources should not come from CRADAs.
Funds derived from the rating AGENCY should not supplant the resources that are useful to support nih research. They can only be used to defuse the cost of the project indicated in the CRADA. Researchers cannot be compensated financially by the IRP for their joint efforts, but they may receive NIH extramural scholarships and scholarships, and they may receive funding from commercial staff (for example. B as part of a research and development cooperation agreement [CRADA]) or other sources outside the NIH.